Mannkind (MNKD) Non-Current Deferred Revenue (2017 - 2026)
Mannkind (MNKD) recorded Non-Current Deffered Revenue of $36.86 million in Q2 2026, down 18.9% from $45.47 million a year earlier and down 5.3% from the prior quarter.
Mannkind (MNKD) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Mannkind reported Non-Current Deffered Revenue of $39.98 million, down 21.9% from FY2024.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of 88.9% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $51.16 million in FY2024 (-26.7%), $69.79 million in FY2023 (+85.2%), $37.68 million in FY2022 (+92.8%) and $19.54 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q3 2022.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for eight consecutive quarters, with an average decline of 22.4% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 117.1% in Q3 2023, against a decline of 31.2% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $38.91 million (Q1 2026), $39.98 million (Q4 2025) and $48.19 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Mannkind | 1.36 Bn | 844.58 Mn | 90.66 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.81 Mn |
| Jun 30, 2026 | 36.86 Mn |
| Mar 31, 2026 | 38.91 Mn |
| Dec 31, 2025 | 39.98 Mn |
| Sep 30, 2025 | 48.19 Mn |
| Jun 30, 2025 | 45.47 Mn |
| Mar 31, 2025 | 47.36 Mn |
| Dec 31, 2024 | 51.16 Mn |
| Sep 30, 2024 | 65.15 Mn |
| Jun 30, 2024 | 66.12 Mn |
| Mar 31, 2024 | 67.74 Mn |
| Dec 31, 2023 | 69.79 Mn |
| Sep 30, 2023 | 69.47 Mn |
| Jun 30, 2023 | 60.25 Mn |
| Mar 31, 2023 | 45.66 Mn |
| Dec 31, 2022 | 37.68 Mn |
| Sep 30, 2022 | 32.00 Mn |
| Jun 30, 2022 | 29.76 Mn |
| Mar 31, 2022 | 26.12 Mn |
| Dec 31, 2021 | 19.54 Mn |
Mannkind Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MNKD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MNKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MNKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();